Basu D - Search Results

1

BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.

Salgado CM, Basu D, Nikiforova M, Bauer BS, Johnson D, Rundell V, Grunwaldt LJ, Reyes-Múgica M. Salgado CM, et al. Among authors: basu d. Pediatr Dev Pathol. 2015 Jan-Feb;18(1):1-9. doi: 10.2350/14-10-1566-OA.1. Epub 2014 Dec 9. Pediatr Dev Pathol. 2015. PMID: 25490715

2

Role of the beta catenin destruction complex in mediating chemotherapy-induced senescence-associated secretory phenotype.

Basu D, Reyes-Mugica M, Rebbaa A. Basu D, et al. PLoS One. 2012;7(12):e52188. doi: 10.1371/journal.pone.0052188. Epub 2012 Dec 18. PLoS One. 2012. PMID: 23272224 Free PMC article.

3

Histone acetylation-mediated regulation of the Hippo pathway.

Basu D, Reyes-Múgica M, Rebbaa A. Basu D, et al. PLoS One. 2013 May 6;8(5):e62478. doi: 10.1371/journal.pone.0062478. Print 2013. PLoS One. 2013. PMID: 23671600 Free PMC article.

4

Skin of patients with large/giant congenital melanocytic nevi shows increased mast cells.

Salgado CM, Silver RB, Bauer BS, Basu D, Schmitt L, Khakoo Y, Reyes-Múgica M. Salgado CM, et al. Among authors: basu d. Pediatr Dev Pathol. 2014 May-Jun;17(3):198-203. doi: 10.2350/14-02-1444-OA.1. Epub 2014 Mar 28. Pediatr Dev Pathol. 2014. PMID: 24679055

5

Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of hippo, TGF-β, and Wnt signaling pathways.

Basu D, Lettan R, Damodaran K, Strellec S, Reyes-Mugica M, Rebbaa A. Basu D, et al. Mol Cancer Ther. 2014 Jun;13(6):1457-67. doi: 10.1158/1535-7163.MCT-13-0918. Epub 2014 Apr 2. Mol Cancer Ther. 2014. PMID: 24694946

6

Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis.

Salgado CM, Basu D, Nikiforova M, Hamilton RL, Gehris R, Jakacki R, Panigrahy A, Yatsenko S, Reyes-Múgica M. Salgado CM, et al. Among authors: basu d. Melanoma Res. 2015 Oct;25(5):453-60. doi: 10.1097/CMR.0000000000000188. Melanoma Res. 2015. PMID: 26266759

7

Nevospheres from neurocutaneous melanocytosis cells show reduced viability when treated with specific inhibitors of NRAS signaling pathway.

Basu D, Salgado CM, Bauer BS, Johnson D, Rundell V, Nikiforova M, Khakoo Y, Gunwaldt LJ, Panigrahy A, Reyes-Múgica M. Basu D, et al. Neuro Oncol. 2016 Apr;18(4):528-37. doi: 10.1093/neuonc/nov184. Epub 2015 Sep 9. Neuro Oncol. 2016. PMID: 26354928 Free PMC article.

8

Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?

Patel J, Salgado CM, Múgica MR, Basu D. Patel J, et al. Among authors: basu d. Neuro Oncol. 2016 Jan;18(1):142-3. doi: 10.1093/neuonc/nov271. Neuro Oncol. 2016. PMID: 26667139 Free PMC article. No abstract available.

9

NRAS Status in Giant Melanocytic Nevus With Metastatic Melanoma.

Salgado CM, Basu D, Reyes-Múgica M. Salgado CM, et al. Among authors: basu d. Am J Dermatopathol. 2016 Aug;38(8):642-3. doi: 10.1097/DAD.0000000000000558. Am J Dermatopathol. 2016. PMID: 27043334 No abstract available.

10

The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis.

Basu D, Salgado CM, Bauer B, Khakoo Y, Patel JR, Hoehl RM, Bertolini DM, Zabec J, Brzozowski MR, Reyes-Múgica M. Basu D, et al. Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):239-248. doi: 10.21873/cgp.20082. Cancer Genomics Proteomics. 2018. PMID: 29976629 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

966 results

Search Page

Filters